Saguaro Biosciences
PrivateLast Round
Grant
Nov 11, 2025
Total Funding Raised
$4.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Saguaro Biosciences operates in Healthcare & Life Sciences and is based in Quebec. Its latest recorded funding round was a Seed round in June 2024.
Saguaro Biosciences is a biotechnology company that develops a live-cell image-based profiling platform designed to accelerate drug discovery and life sciences research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Saguaro Biosciences Comparables
Compare Saguaro Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biotium | 74% | |
| CytoTronics | 73% | |
| Sartorius Aktiengesellschaft | 73% |
For institutional investors. Book with your work email.
Saguaro Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 11, 2025 | ||||
| Seed | Jun 4, 2024 | ||||
| Pre Seed | Feb 16, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Saguaro Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Seed |
| Consortium Québécois sur la découverte du médicament | Grant |
| AQC Capital | Seed |
| Anges Quebec | Seed |
| Ville de Québec | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
Open roles increased to 4, representing 27% of headcount.
- Aug 21, 2026
Monthly visitors increased 177% MoM, reaching 5.7K.
For institutional investors. Book with your work email.
Saguaro Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Saguaro Biosciences's valuation, stock price, and market status.
Is Saguaro Biosciences a public or private company?
Saguaro Biosciences is a private company.
What is the current stock price of Saguaro Biosciences?
Saguaro Biosciences is a private company, so its shares have no public market price. Caplight tracks Saguaro Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Saguaro Biosciences worth (valuation)?
Valuation information for Saguaro Biosciences is not publicly available.
Can I buy Saguaro Biosciences stock?
Saguaro Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Saguaro Biosciences's last funding round?
Saguaro Biosciences's most recent funding round was Grant on November 11, 2025.
Who are the main investors in Saguaro Biosciences?
Key investors in Saguaro Biosciences include AQC Capital, Anges Quebec.
Will Saguaro Biosciences IPO soon?
No public IPO plans have been announced for Saguaro Biosciences.
How can I track Saguaro Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Saguaro Biosciences's shares on secondary markets.